Motus GI Stock (NASDAQ:MOTS)


RevenueOwnershipFinancialsChart

Previous Close

-

52W Range

- - $5.67

50D Avg

$0.03

200D Avg

$0.21

Market Cap

$2.56K

Avg Vol (3M)

$59.48K

Beta

1.93

Div Yield

-

MOTS Company Profile


Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

15

IPO Date

Feb 14, 2018

Website

MOTS Performance


MOTS Financial Summary


Dec 23Dec 22Dec 21
Revenue$319.00K$592.00K$391.00K
Operating Income$-11.91M$-17.85M$-17.92M
Net Income$-12.87M$-18.09M$-18.91M
EBITDA$-11.91M$-17.30M$-18.06M
Basic EPS$-0.02$-83.81$-120.98
Diluted EPS$-0.02$-83.81$-120.98

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 22Nov 14, 22 | 6:44 PM
Q2 22Aug 11, 22 | 9:27 PM
Q1 22May 12, 22 | 8:58 PM

Peer Comparison


TickerCompany
VYNEVYNE Therapeutics Inc.
ECORelectroCore, Inc.
CHEKCheck-Cap Ltd.
NDRAENDRA Life Sciences Inc.
ALRNAileron Therapeutics, Inc.